Oral challenge vs routine care to assess low-risk penicillin allergy in critically ill hospital patients (ORACLE): a pilot safety and feasibility randomised controlled trial
- Author(s)
- Rose, MT; Holmes, NE; Eastwood, GM; Vogrin, S; James, F; De Luca, JF; Bellomo, R; Warrillow, SJ; Phung, M; Barnes, SL; Murfin, B; Rogers, B; Lambros, B; Collis, B; Peel, TN; Slavin, MA; Trubiano, JA;
- Journal Title
- Intensive Care Medicine
- Publication Type
- Research article
- Abstract
- PURPOSE: Critically ill patients are vulnerable to penicillin allergy labels that may be incorrect. The validity of skin testing in intensive care units (ICUs) is uncertain. Many penicillin allergy labels are low risk, and validated tools exist to identify those amenable to direct oral challenge. This pilot randomised controlled trial explored the feasibility, safety, and validity of direct enteral challenge for low-risk penicillin allergy labels in critical illness. METHODS: Consenting patients with a low-risk penicillin allergy label (PAL) (PEN-FAST risk assessment score < 3) in four ICUs (Melbourne, Australia) were randomised 1:1 to penicillin (250 mg amoxicillin or implicated penicillin) direct enteral challenge versus routine care (2-h post-randomisation observation for each arm). Repeat challenge was performed post -ICU in the intervention arm. Patients were reviewed at 24 h and 5 days after each challenge/observation. RESULTS: We screened 533 patients. 130 (24.4%) were eligible and 80/130 (61.5%) enrolled (age median 64.5 years (interquartile range, IQR 53.5, 74), PEN-FAST median 1 (IQR 0,1)), with 40 (50%) randomised to direct enteral challenge. A positive challenge rate of 2.5% was identified. No antibiotic-associated serious adverse events were identified. 32/40 (80%) received a repeat challenge (zero positive). Post-randomisation, 13 (32%) of the intervention arm and 4 (10%) of the control arm received penicillin (odds ratio, OR 4.33 [1.27, 14.78] p = 0.019). CONCLUSION: These findings support the safety, validity, and feasibility of direct enteral challenge for critically ill patients with PEN-FAST assessed low-risk penicillin allergy. The absence of false negative results was confirmed by subsequent negative repeat challenges. A relatively low recruitment to screened ratio suggests that more inclusive eligibility criteria and integration of allergy assessment into routine ICU processes are needed to optimise allergy delabelling in critical illness.
- Publisher
- BioMed Central
- Keywords
- Allergy and immunology; Antibiotics; Critical care; Direct oral challenge; Drug hypersensitivity; Oral provocation; Penicillins
- Department(s)
- Infectious Diseases
- Publisher's Version
- https://doi.org/10.1007/s00134-024-07448-x
- Open Access at Publisher's Site
https://doi.org/10.1007/s00134-024-07448-x- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2024-07-17 07:22:36
Last Modified: 2024-07-17 07:24:34